NIKE, Inc. NKE
NYSE · XNYS · stock
Chart by TradingView
4/9
Piotroski F — financial health
—
Altman Z″ — distress risk
71.5%
Dividend payout · stretched
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $46.3B | $3.2B | $19.8B | $3.3B | $13.2B |
| 2024 | $51.4B | $5.7B | $22.9B | $6.6B | $14.4B |
| 2023 | $51.2B | $5.1B | $22.3B | $4.9B | $14.0B |
| 2022 | $46.7B | $6.0B | $21.5B | $4.4B | $15.3B |
| 2021 | $44.5B | $5.7B | $20.0B | $6.0B | $12.8B |
| 2020 | $37.4B | $2.5B | $16.2B | $1.4B | $8.1B |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0000320187 · as of 2025-05-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.